Sodium Hydroxide → 3-Methyl-2-(4-methyl-2-(piperidin-1-yl)-6-p-tolylpyrimidin-5-yl)pentanoic acid
Reaction equation
[CH3:1][CH:2]([CH2:28][CH3:29])[CH:3]([C:8]1[C:9]([CH3:27])=[N:10][C:11]([N:21]2[CH2:26][CH2:25][CH2:24][CH2:23][CH2:22]2)=[N:12][C:13]=1[C:14]1[CH:19]=[CH:18][C:17]([CH3:20])=[CH:16][CH:15]=1)[C:4]([O:6]C)=[O:5].[OH-].[Na+]>CO>[CH3:1][CH:2]([CH2:28][CH3:29])[CH:3]([C:8]1[C:9]([CH3:27])=[N:10][C:11]([N:21]2[CH2:26][CH2:25][CH2:24][CH2:23][CH2:22]2)=[N:12][C:13]=1[C:14]1[CH:19]=[CH:18][C:17]([CH3:20])=[CH:16][CH:15]=1)[C:4]([OH:6])=[O:5]Participants
4
Procedure
This compound was prepared according to general method D from methyl 3-methyl-2-(4-methyl-2-(piperidin-1-yl)-6-p-tolylpyrimidin-5-yl)pentanoate (0.039 g; 0.099 mmol), sodium hydroxide 10N (0.100 mL; 0.1 mmol) in methanol (1 mL) to afford 0.028 g (73%) of the title compound as a white solid.
Workup
- customThis compound was prepared
Sources & evidence
- ORD record
- ord-c648c8fdddcc424a8ee1b71ae8bf836d
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08906906B2
Reaction notes
Loading…